Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ranjan Chakrabarti. (2009) Pharmacotherapy of obesity: emerging drugs and targets. Expert Opinion on Therapeutic Targets 13:2, pages 195-207.
Read now
Read now
Harold Bays & Carlos Dujovne. (2002) Anti-obesity drug development. Expert Opinion on Investigational Drugs 11:9, pages 1189-1204.
Read now
Read now
David W Laight. (2002) Therapeutic approaches to the management of dysmetabolic cardiovascular disease. Expert Opinion on Therapeutic Patents 12:5, pages 615-620.
Read now
Read now
David A Shapiro & Bryan L Roth. (2001) Insights into the structure and function of 5-HT2 familyserotonin receptors reveal novel strategies for therapeutic target development. Expert Opinion on Therapeutic Targets 5:6, pages 685-695.
Read now
Read now
Articles from other publishers (22)
Alhanouf S. Al‐Alsheikh, Shahd Alabdulkader, Alexander D. Miras & Anthony P. Goldstone. (2023) Effects of bariatric surgery and dietary interventions for obesity on brain neurotransmitter systems and metabolism: A systematic review of positron emission tomography (PET) and single‐photon emission computed tomography (SPECT) studies. Obesity Reviews.
Crossref
Crossref
Glauber Rudá F. Braz, Aline Isabel da Silva, Severina Cássia A. Silva, Anderson Apolonio S. Pedroza, Maria Daniele T.B. de Lemos, Flávia Ariane S. de Lima, Tercya Lúcidi A. Silva & Claudia Jacques Lagranha. (2020) Chronic serotonin reuptake inhibition uncouples brown fat mitochondria and induces beiging/browning process of white fat in overfed rats. Life Sciences 245, pages 117307.
Crossref
Crossref
E. NUNAMAKER, K. NEWHALL, C. THOMPSON, A. LUCAS, J. OWENS & J. G. SHERMAN. (2011) Safety evaluation and treatment affect of LY2190416, a CB-1 antagonist/inverse agonist in growing beagle dogs. Journal of Veterinary Pharmacology and Therapeutics 34:6, pages 577-582.
Crossref
Crossref
David Stegner & Bernhard Nieswandt. (2010) Platelet receptor signaling in thrombus formation. Journal of Molecular Medicine 89:2, pages 109-121.
Crossref
Crossref
K. NEWHALL, E. NUNAMAKER, S. GISSENDANNER, C. THOMPSON, J. OWENS, A. LUCAS & J. G. SHERMAN. (2010) CB-1 antagonism with LY2190416 results in acute weight loss in obese adult dogs fed a high-fat diet. Journal of Veterinary Pharmacology and Therapeutics 33:6, pages 615-618.
Crossref
Crossref
Sheo B. Singh, Olga Genilloud & Fernando Peláez. 2010. Comprehensive Natural Products II. Comprehensive Natural Products II
109
140
.
Elena Valassi, Massimo Scacchi & Francesco Cavagnini. (2008) Neuroendocrine control of food intake. Nutrition, Metabolism and Cardiovascular Diseases 18:2, pages 158-168.
Crossref
Crossref
Mark J. Millan. (2006) Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacology & Therapeutics 110:2, pages 135-370.
Crossref
Crossref
Bernard Beck, Brigitte Fernette & Alain Stricker-Krongrad. (2005) Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochemical and Biophysical Research Communications 332:3, pages 859-865.
Crossref
Crossref
P. Hanumantharao, S.V. Sambasivarao, Love K. Soni, A.K. Gupta & S.G. Kaskhedikar. (2005) QSAR analysis of thiazole benzenesulfonamide substituted 3-pyridylethanolamines as ?3-adrenergic receptor agonist. Bioorganic & Medicinal Chemistry Letters 15:12, pages 3167-3173.
Crossref
Crossref
Harold E. Bays. (2012) Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets. Obesity Research 12:8, pages 1197-1211.
Crossref
Crossref
D. N. D'Souza, Y. Zhang, F. Garcia, G. Battaglia & L. D. Van de Kar. (2004)
Fluoxetine-induced changes in body weight and 5-HT
1A
receptor-mediated hormone secretion in rats on a tryptophan-deficient diet
. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 286:2, pages R390-R397.
Crossref
Crossref
Tim C Kirkham & Claire M Williams. (2004) Endocannabinoid Receptor Antagonists. Treatments in Endocrinology 3:6, pages 345-360.
Crossref
Crossref
Y Ishii, J.E Blundell, J.C.G Halford & R.J Rodgers. (2003) Palatability, food intake and the behavioural satiety sequence in male rats. Physiology & Behavior 80:1, pages 37-47.
Crossref
Crossref
M. Bensaid, M. Gary-Bobo, A. Esclangon, J. P. Maffrand, G. Le Fur, F. Oury-Donat & P. Soubrié. (2003)
The Cannabinoid CB
1
Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells
. Molecular Pharmacology 63:4, pages 908-914.
Crossref
Crossref
R.J. Rodgers, Y. Ishii, J.C.G. Halford & J.E. Blundell. (2002) Orexins and appetite regulation. Neuropeptides 36:5, pages 303-325.
Crossref
Crossref
Sandra Eiden, Carolin Daniel, Alexandra Steinbrueck, Ingrid Schmidt & Eckhart Simon. (2002) Salmon calcitonin – a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents. The Journal of Physiology 541:3, pages 1041-1048.
Crossref
Crossref
Robert F. Kushner & Hazel Manzano. (2002) Obesity pharmacology: past, present, and future. Current Opinion in Gastroenterology 18:2, pages 213-220.
Crossref
Crossref
Brian L Largent, Albert J Robichaud & Keith J Miller. 2002. Annual Reports in Medicinal Chemistry Volume 37. Annual Reports in Medicinal Chemistry Volume 37
1
10
.
Jefferson W. Tilley. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
Christos S. Mantzoros. (2001) The role of leptin and hypothalamicneuropeptides in energy homeostasis: Update on leptin in obesity. Growth Hormone & IGF Research 11, pages S85-S89.
Crossref
Crossref
B. Beck. (2001) KO's and organisation of peptidergic feeding behavior mechanisms. Neuroscience & Biobehavioral Reviews 25:2, pages 143-158.
Crossref
Crossref